| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.075 | 0.09 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |